Explore our off-the-shelf organoid screens

ONCOLOGY

PDO Screen

Evaluate the efficacy of your compound in patient-derived tumor organoids
Link

TOXICOLOGY

HumanTox Insight

Understand animal-to-human translatability for your preclinical toxicology research
Link

License HUB Organoid Technology

INFLAMMATION

IntegriGut Screen

Access the protective effect of your compound against epithelial damage
Link

SCREEN OF THE MONTH

KRASmut Screen

Test the efficacy of your KRAS inhibitor(s) with confidence

enroll now

 

NEW LAUNCH!

ADC Organoid Screen

Predict the therapeutic effect of your ADCs with patient-derived organoid technology

learn more

Our therapeutic areas

Oncology

Immuno-oncology

Inflammatory diseases

Genetic
diseases

Infectious diseases

Toxicology

Custom model and assay development

Can’t find what you are looking for? Leverage our state-of-the-art technology to develop new models that meet your specific needs.

discover more

 

Want to know more?

NEWS AND INSIGHTS

First clinical candidate developed using HUB Organoids makes it to the clinical trials within five years

read more

WHITEPAPER

Accelerating oncology drug discovery using HUB Organoids

download now

POSTER

Patient-derived organoids predict clinical response: a patient in the lab

download now

Begin your organoid study with us

Share your screening parameters with us. Our experts will get in touch with you shortly.
X

Have any questions?

contact us
PRESS RELEASE

Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

learn more

Powered by